Home - Products - Others - Other Targets - Vesicular Stomatitis Virus peptide

Vesicular Stomatitis Virus peptide

CAS No. ———

Vesicular Stomatitis Virus peptide( ——— )

Catalog No. M41823 CAS No. ———

Vesicular Stomatitis Virus peptide

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Vesicular Stomatitis Virus peptide
  • Note
    Research use only, not for human use.
  • Brief Description
    Vesicular Stomatitis Virus peptide
  • Description
    Vesicular Stomatitis Virus peptide
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    955.09
  • Molecular Formula
    C44H66N12O12
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Propyl heptanoate

    Propyl heptanoate is an important chemical raw material and an organic solvent in the industrial field. It can be used in synthetic fragrances, nylon fibers and advanced plastics.

  • Hordenine hydrochlor...

    Hordenine (hydrochloride), an alkaloid found in plants, inhibits melanogenesis by suppression of cyclic adenosine monophosphate (cAMP) production.

  • Syk Inhibitor II hyd...

    The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.